What We Know. What We’re Learning. What Remains Unknown.
Research into ayahuasca, psychedelics, the brain, context and integration is moving quickly.
Some findings are compelling. Others are early. And some of the most important questions remain unanswered.
At MERAYA, we believe evidence becomes more useful—not less—when we are clear about its limits.
Explore the evidence below ↓
WHY EVIDENCE MATTERS
Powerful Experiences Deserve Careful Interpretation
A profound experience can change the way someone feels, thinks, relates and understands their life.
Science can measure some of those changes.
But measuring change is not the same as knowing exactly what caused it, why it happened, how long it will last, or what it ultimately means.
The strongest psychedelic research can often tell us whether measurable changes occurred under a particular protocol. It becomes less certain when we ask which part of the experience caused the change—or how an extraordinary state becomes an ordinary way of living.
A powerful experience is evidence that something happened. It is not automatically proof of why it happened.
HOW WE READ THE RESEARCH
Five Levels of Evidence
FACT
A finding supported strongly enough to describe directly.
PROMISING EVIDENCE
Meaningful evidence exists, but replication, scale or certainty is still limited.
ASSOCIATION
Two things are related, but we cannot yet say one caused the other.
HYPOTHESIS
A scientifically plausible explanation worth investigating.
UNKNOWN
The evidence does not currently justify an answer.
WHAT RESEARCH IS FINDING
Ayahuasca and Psychedelic Research
AYAHUASCA & DEPRESSION
A small randomized placebo-controlled study involving 29 people with treatment-resistant depression found rapid reductions in depressive symptoms following a single ayahuasca session, particularly around seven days later.
Promising evidence—not proof of an established treatment.
JOHNS HOPKINS — PSILOCYBIN & PSYCHOLOGICAL DISTRESS
In a randomized double-blind study of 51 people facing life-threatening cancer, Johns Hopkins researchers found that a high-dose psilocybin session delivered under psychologically supportive conditions was followed by substantial reductions in depression and anxiety.
Many improvements remained measurable six months later. The findings come from a carefully selected population and controlled clinical protocol.
BROADER AYAHUASCA OUTCOMES
A 2026 systematic review of 18 prospective studies found reported changes across wellbeing, depressive symptoms, substance use, cognitive flexibility, personality-related measures and prosocial functioning.
The same review emphasized small samples, inconsistent preparations, limited controls and many self-selected retreat participants.
PSILOCYBIN & DEPRESSION
Several controlled trials have found substantial reductions in depression among carefully selected participants receiving psilocybin within structured therapeutic settings.
But findings are not uniformly positive. In one important comparison, psilocybin did not significantly outperform escitalopram on the primary depression outcome, although several secondary outcomes favored psilocybin.
Good science should not require us to hide the studies that complicate the story.
The science is promising. Promising is not the same as proven.
WHAT RESEARCHERS ARE LEARNING ABOUT THE PSYCHEDELIC BRAIN
The Brain Enters an Unusual State
Human brain-imaging studies show that psychedelics can temporarily change communication within and between large-scale brain networks. Research involving both ayahuasca and psilocybin has documented changes involving the default mode network, network segregation, global integration and desynchronization.
Those measurements are real. Their meaning is still being investigated.
BRAIN NETWORKS
Fact. Psychedelics measurably alter patterns of brain connectivity.
NEUROPLASTICITY
Promising / incomplete. Psychedelics promote structural and functional plasticity in cells and animal models. Human evidence is much less direct.
‘REWIRING THE BRAIN’
Not established. Popular language about ‘resetting’ or ‘rewiring’ the brain goes further than current human evidence allows.
Science can measure a changed brain state. It cannot yet tell us everything that state means.
THE MOLECULE IS NOT THE WHOLE EXPERIENCE
Context Matters
Modern psychedelic research does not usually consist of simply giving someone a molecule. Serious protocols commonly include screening, preparation, a controlled environment, human support and follow-up.
Research also suggests that several contextual factors may influence people’s experiences and later outcomes.
RELATIONSHIP
The quality of the therapeutic relationship has been associated with aspects of the psychedelic experience and later psychological outcomes.
MUSIC & ENVIRONMENT
How participants respond to music has been associated with both acute psychedelic experiences and later outcomes.
GROUP & CONNECTION
Naturalistic research suggests that stronger feelings of shared connection—or communitas—can predict later wellbeing and social connectedness.
The medicine may matter. The context matters too.
FROM STATE TO TRAIT
An Experience Is Not Yet Development
This is where the science intersects most directly with the MERAYA System.
Psychedelic experiences can be followed by psychological changes lasting weeks or months. But the intensity of an experience does not itself demonstrate durable development.
Integration is widely used throughout psychedelic practice, yet researchers still do not know which integration methods work best, for whom, or how much integration itself contributes to longer-term outcomes.
MERAYA therefore makes a distinction:
Experience may reveal.
Development asks what you learn to live.
Our educational model places emphasis not only on what happens during an experience, but on what happens afterward:
What do you practise?
How do you respond under pressure?
What changes in your relationships?
What becomes more dependable?
What responsibility comes next?
Insight can happen in a moment. A different way of living is learned over time.
IMMERSIVE TRANSFORMATION
Can Intensive Experiences Create Measurable Change?
This question matters to MERAYA because our educational experiences are influenced in part by immersive transformational-event models.
A small randomized study published in the Journal of Psychiatric Research examined 45 participants attending Tony Robbins’ six-day Date With Destiny program followed by 30 days of structured exercises.
Participants in the intervention group showed improvements in depression-related measures and wellbeing.
The result is interesting. It is also preliminary.
The study was small, tested an entire package rather than individual components, and has not independently established a general ‘Tony Robbins method.’
For MERAYA, we take a narrower lesson: immersive educational environments can produce measurable psychological change. What creates that change—and what makes it last—still requires research.
TWO DIFFERENT LENSES
Science and Traditional Knowledge Are Not the Same Language
Science is designed to measure observable effects. Amazonian traditions carry histories, relationships, practices, cultural knowledge and interpretations that do not always fit neatly inside biomedical categories.
We do not need one system to pretend to be the other.
Science may ask: drug → receptor → brain network → symptom.
Traditional systems may ask about relationships between: person → family → community → healer → plants → territory → diet → ceremony → responsibility.
Science can investigate measurable outcomes. Traditional knowledge can preserve ways of understanding experience that science was never designed to replace.
SAFETY IS PART OF THE SCIENCE
Potential Does Not Remove Risk
The same research showing potential benefits also shows the need for caution.
A large international survey involving 10,836 ayahuasca participants found that difficult physical and psychological effects were common, while a smaller proportion of participants sought medical or professional psychological support.
Controlled psychedelic trials also carefully screen participants. That distinction matters because research conducted in selected populations cannot automatically tell us what happens to every person who wants to participate.
The scientific question is not simply ‘Can this help?’ It must also include: ‘For whom? Under what conditions? And at what risk?’
Detailed screening, medication, psychiatric and cardiovascular guidance belongs on our dedicated Medical Guidelines & Safety page.
THE QUESTIONS STILL OPEN
What Science Cannot Yet Tell Us
WHO BENEFITS MOST?
Researchers still need better ways to predict benefit, non-response and deterioration.
WHAT ACTUALLY CAUSES CHANGE?
Drug, expectation, preparation, support, environment and integration are usually delivered together.
HOW LONG DOES CHANGE LAST?
Months of follow-up are common. Rigorous multi-year evidence is much thinner.
DOES INTEGRATION WORK?
Integration is widely practised, but surprisingly little research has isolated and tested it directly.
ARE MYSTICAL EXPERIENCES NECESSARY?
They sometimes predict outcomes. That does not prove they cause them.
HOW DOES INSIGHT BECOME BEHAVIOUR?
Perhaps the question most relevant to MERAYA—and one science has not yet answered.
THE MERAYA POSITION
Curiosity Without Gullibility
We do not need science to dismiss extraordinary experience.
And we do not need extraordinary experience to make science say more than it knows.
Research shows that profound experiences can be followed by real psychological change. Science is beginning to understand some of the biological, psychological, relational and contextual processes involved.
It does not yet fully understand how an experience becomes a life.
That is where inquiry continues.
SELECTED RESEARCH
Read the Studies
Ayahuasca & treatment-resistant depression
Palhano-Fontes et al. (2019), Psychological Medicine
A single ayahuasca session was followed by rapid reductions in depressive symptoms in a small treatment-resistant depression trial.
Johns Hopkins psilocybin study
Griffiths et al. (2016), Journal of Psychopharmacology
Psilocybin with psychological support was followed by substantial reductions in depression and anxiety, with many improvements still measurable six months later.
Prospective ayahuasca systematic review
Haupt et al. (2026)
Across 18 prospective ayahuasca studies, researchers reported changes in wellbeing, depression, substance use, cognitive flexibility and prosocial functioning.
Psilocybin & major depressive disorder
Davis et al. (2021), JAMA Psychiatry
Two psilocybin sessions with psychological support produced substantial short-term reductions in major-depression symptoms in a small clinical trial.
Psilocybin vs escitalopram
Carhart-Harris et al. (2021), New England Journal of Medicine
Psilocybin did not significantly outperform escitalopram on the primary depression outcome, though several secondary measures favored psilocybin.
Brain-network integration after psilocybin
Daws et al. (2022), Nature Medicine
Psilocybin response was associated with greater communication across brain networks, offering a measurable window into altered brain organization.
Psychedelic communitas
Kettner et al. (2021)
Stronger feelings of shared connection during group psychedelic experiences predicted greater later wellbeing and social connectedness.
Evidence gap around psychedelic integration
Greń et al. (2024)
Integration is widely recommended after psychedelic experiences, but direct evidence identifying which methods work best remains limited.
Global Ayahuasca Survey
Bouso et al. (2022)
A large international survey documented both reported benefits and common difficult physical or psychological effects, highlighting the importance of screening and support.
Date With Destiny randomized trial
Ganz et al. (2022)
A small randomized study found improved depression-related measures and wellbeing after Date With Destiny plus 30 days of follow-up exercises.
Ayahuasca & treatment-resistant depression
Palhano-Fontes et al. (2019), Psychological Medicine
A single ayahuasca session was followed by rapid reductions in depressive symptoms in a small treatment-resistant depression trial.
Johns Hopkins psilocybin study
Griffiths et al. (2016), Journal of Psychopharmacology
Psilocybin with psychological support was followed by substantial reductions in depression and anxiety, with many improvements still measurable six months later.
Prospective ayahuasca systematic review
Haupt et al. (2026)
Across 18 prospective ayahuasca studies, researchers reported changes in wellbeing, depression, substance use, cognitive flexibility and prosocial functioning.
Psilocybin & major depressive disorder
Davis et al. (2021), JAMA Psychiatry
Two psilocybin sessions with psychological support produced substantial short-term reductions in major-depression symptoms in a small clinical trial.
Psilocybin vs escitalopram
Carhart-Harris et al. (2021), New England Journal of Medicine
Psilocybin did not significantly outperform escitalopram on the primary depression outcome, though several secondary measures favored psilocybin.
Brain-network integration after psilocybin
Daws et al. (2022), Nature Medicine
Psilocybin response was associated with greater communication across brain networks, offering a measurable window into altered brain organization.
Psychedelic communitas
Kettner et al. (2021)
Stronger feelings of shared connection during group psychedelic experiences predicted greater later wellbeing and social connectedness.
Evidence gap around psychedelic integration
Greń et al. (2024)
Integration is widely recommended after psychedelic experiences, but direct evidence identifying which methods work best remains limited.
Global Ayahuasca Survey
Bouso et al. (2022)
A large international survey documented both reported benefits and common difficult physical or psychological effects, highlighting the importance of screening and support.
Date With Destiny randomized trial
Ganz et al. (2022)
A small randomized study found improved depression-related measures and wellbeing after Date With Destiny plus 30 days of follow-up exercises.
THE PATH CONTINUES
Continue Exploring
DISCOVERY CALL
For in-person Jungle Initiations, enrollment is available by Discovery Call only.
NOT SURE WHICH PATH IS RIGHT FOR YOU?
You may be exploring personal healing, deeper shamanic development, online training, or an immersive journey into the Amazon.
You do not need to figure it all out alone.
Book a personal discovery call with MERAYA to ask your questions, explore the different ways to work with us, and understand which pathway may best support where you are now.
No pressure. Just a conversation, clarity, and a clear next step.
JOIN THE MERAYA COMMUNITY
JOIN THE MERAYA COMMUNITY
Stay connected to the teachings, trainings and conversations emerging from Meraya.
For now, join the community and receive our free Ayahuasca Masterclass video training, together with ongoing teachings on plant medicine, shamanic development, integration and walking the path with greater clarity.
Join a growing community of people committed to healing, development and living what they learn.
Walk The Shamanic Path With Clarity
GROW DEEP. SERVE WELL.
